B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Amikacin

298 PubMed studies analyzed ยท 29 RCTs ยท Evidence Score: 46.2

Research Domains

Amikacin has been studied across 16 research domains including ๐Ÿซ˜ Kidney, ๐Ÿง  Focus & Attention, ๐Ÿ”ฌ Oncology, ๐Ÿซ Respiratory, ๐Ÿซ Liver & Detox. The primary research focus is ๐Ÿซ˜ Kidney with 14% of studies addressing this area.

Loading evidence profile...

This evidence profile for Amikacin is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.